| Literature DB >> 31844632 |
Jonas Hedegaard Andersen1,2, Anne Rasmussen1, Marie Frimodt-Møller1, Peter Rossing1,3, Klaus Kirketerp-Møller1,4, Susanne Engberg1.
Abstract
AIM: The aim of this study was to evaluate outcomes of needle tenotomies as a treatment option for hammer, mallet and claw toes in patients with diabetes.Entities:
Keywords: Deformities; Diabetic foot ulcer; Needle; Offloading; Preventive surgery; Tenotomy
Year: 2019 PMID: 31844632 PMCID: PMC6896484 DOI: 10.1016/j.jcte.2019.100208
Source DB: PubMed Journal: J Clin Transl Endocrinol ISSN: 2214-6237
Baseline characteristics.
| Patients with ulcers | Patients without ulcers | P-Value | ||
|---|---|---|---|---|
| 28 | 53 | |||
| Men | 24 (86%) | 31 (58%) | ||
| Age (years) | 62.8 ± 9 | 66.9 ± 12 | 0.04 | |
| Diabetes duration (years) | 24 ± 15.2 | 27.7 ± 16.4 | 0.35 | |
| Type 1 DM | 10 (36%) | 17 (32%) | 0.8 | |
| Smoker | 3 (11%) | 8 (15%) | 0.7 | |
| Alcohol-abuse | 3 (11%) | 7 (13%) | 1.0 | |
| BMI (kg/m2) | 32.3 ± 6.3 | 29.6 ± 4.6 | 0.08 | |
| Systolic BP (mmHg) | 135 ± 21 | 132 ± 17 | 0.6 | |
| Diastolic BP (mmHg) | 73 ± 10 | 74 ± 9 | 0.92 | |
| HbA1c | 8.1 ± 3.3 (65 ± 13) | 7.7 ± 3.5 (61 ± 15) | 0.11 | |
| eGFR (ml/min/1,73 m2) | 68.8 ± 20.6 | 70.3 ± 21.7 | 0.6 | |
| p-LDL (mmol/l) (median (Q1-3)) | 1.9 (1.4–2.5) | 1.9 (1.4–2.2) | 0.8 | |
| p-Triglycerides (mmol/l) (median (Q1-3)) | 1.8 (1.2–2.6) | 1.6 (0.9–2.4) | 0.22 | |
| Urine-albumin-creatinine ratio, median (mg/g) (median (Q1-3)) | 39 (10–314) | 18 (5–65) | 0.05 | |
| Vibration threshold > 25 V | 28 (100%) | 47 (89%) | 0.9 | |
| Vibration threshold > 50 V | 25 (89%) | 32 (60%) | 0.01 | |
| Absent monofilament sensation on either foot | 24 (86%) | 36 (68%) | 0.11 | |
| Charcot foot | 5 (18%) | 8 (15%) | 0.75 | |
| No palpable pulse in either foot | 6 (21%) | 10 (19%) | 0.77 | |
| Follow-up (weeks) | 104.9 ± 44.8 | 92.9 ± 46.5 | 0.39 | |
| Mors during follow up | 3 (11%) | 5 (9%) | 1.0 |
Total and divided into patients with ulcers and patients without ulcers (Categorical data is given as number of patients with % in parenthesis. Continuous data is reported as mean with standard deviation if nothing else is noted).
Estimated glomerular filtration rate (e-GFR) is calculated from the chronic kidney disease epidemiology collaboration equation.
p-LDL = plasma low density lipoproteins.
HbA1C is reported in NGSP (%) followed by IFCC (mmol/mol).
Tenotomy characteristics.
| Patients with ulcers | Patients without ulcers | P-Value | ||
|---|---|---|---|---|
| 36 | 70 | |||
| Number of toes operated | 62 | 231 | ||
| Offloading procedure of at least one toe | 14 | 70 | ||
| Progression to active ulcer after preventive procedure of at least one toe per procedure | 1 (7%) | 5(7%) | 1.0 | |
| Time of ulcer before tenotomy (weeks) (median(Q1-3)) | 4.5 (2.0–8.5) | N/A | N/A | |
| Ulcer healed | 34 (94%) | N/A | N/A | |
| Mean time to ulcer healing (days) | 28 ± 35.2 | N/A | N/A | |
| Healing of incision | 36 (100%) | 70 (100%) | 1.0 | |
| Mean time to Incision healing (days) | 4.3 ± 2.5 | 4.5 ± 2.6 | 0.36 | |
| Ulcer diagnosis | N/A | N/A | ||
| Ischemic | 3 (8%) | |||
| Neuropathic | 28 (78%) | |||
| Neuro-ischemic | 5 (14%) | |||
| Ulcer recurrence | 5 | N/A | N/A | |
| Transfer lesions | ||||
| Total | 12 (33%) | 13 (19%) | 0.43 | |
| Ulcer | 5 (14%) | 2 (3%) | 0.17 | |
| Impending ulcer | 7 (19%) | 11 (16%) | 0.79 | |
| Minor amputations | 1 (3%) | 2 (3%) | 1.0 | |
| Major amputation | 1 (3%) | 0 | 0.35 | |
| Infections | 0 | 0 | 1.0 | |
| Re-tenotomi | 1 (3%) | 3 (4%) | 1.0 | |
| Extensor tenotomi | 0 | 4 (6%) | 0.3 | |
| Pain | 0 | 14 (20%) |
Total and divided into procedures on patients with ulcers and procedures on patients without ulcers.
P-value refers to patient with ulcers compared with patients without ulcers.
% of 84 offloading procedures.
Recurrence was calculated as 5/34, where the 34 is the 34 patients who achieved ulcer healing.
Fig. 1Comparison of outcomes. Comparison of outcomes between our study and five studies of tenotomies performed with scalpel [10], [14], [21], [22], [23].
Transfer lesions.
| Procedures on all toes | Procedures on some toes | P-Value* | ||
|---|---|---|---|---|
| 16 | 90 | |||
| Number of toes operated | 96 | 197 | ||
| Follow-up (weeks) | 94.5 (±39.3) | 97.4 (±47.4) | 0.92 | |
| Healing of incision | 16 (100%) | 90 (100%) | 1.0 | |
| Incision time to healing (days) | 5.1 (±2.5) | 4.3 (±2.5) | 0.26 | |
| Transfer lesions | ||||
| Total | 0 (0%) | 25 (28%) | ||
| Ulcer | 0 (0%) | 7 (8%) | 0.59 | |
| Impending Ulcer | 0 (0%) | 18 (20%) | 0.07 | |
| Minor Amputations | 1 (6%) | 2 (2%) | 0.39 | |
| Major Amputation | 0 (0%) | 1 (1%) | 1.0 | |
| Infections | 0 | 0 | 1.0 | |
| Re-tenotomi | 0 | 4 (4%) | 1.0 | |
| Extensor Tenotomi | 1 (6%) | 3 (3%) | 0.49 | |
| Pain | 4 (25%) | 10 (11%) | 0.22 |
Total and divided into procedures on patients who received tenotomy off all toes and less than all toes.
Comparison between current and prior study baseline characteristics.
| Current study | Rasmussen et al. 2013 | Ratio | |
|---|---|---|---|
| 81 | 38 | ||
| Men | 55 (68%) | 30 (79%) | 0.9 |
| Age (years) | 65.4 | 62.8 | 1.0 |
| Diabetes duration (years) | 26.4 | 23.5 | 1.1 |
| Type 1 DM | 27 (33%) | 14 (37%) | 0.9 |
| Smoker | 11 (14%) | 7 (18%) | 0.8 |
| Alcohol-abuse | 10 (12%) | 3 (11%) | 1.1 |
| BMI (kg/m2) | 30.5 | 32.2 | 0.9 |
| HbA1c* (%, mmol/mol) | 7.9 (63) | 8.2 (66) | 1 |
| Vibration threshold >25 V | 75 (93%) | 34 (90%) | 1 |
| Vibration threshold >50 V | 57 (70%) | 31 (82%) | 0.9 |
| Absent monofilament sensation on either foot | 60 (74%) | 32 (84%) | 0.9 |
| Charcot foot | 13 (16%) | 3 (8%) | 2 |
| No palpable pulse in either foot | 16 (20%) | 7 (18%) | 1 |
| Follow-up (months) | 22 | 31 | 0.7 |